白血病小鼠模型中P53、C-myc基因表达的变化研究

探讨DNA、RNA病毒诱导小鼠发生白血病的机制。用单纯疱疹病毒Ⅱ型（HSV－2）和C型RNA病毒诱导70只昆明小鼠，光学显微镜检测HSV－2、C型病毒诱导发生白血病的成功率。正常对照组为30只昆明小鼠。免疫组化法检测HSV－2、C型病毒致瘤后P^53、G－myc基因表达的变化。70只昆明小鼠中有47只发生白血病，成功率为67．1％。47只白血病小鼠P^53、C－myc蛋白阳性表达率均比正常对照组高（P＜0．05）；23只未形成白血病的实验组小鼠P^53、C－myc蛋白阳笥表达率均与正常对照组无显差异（P＞0．05）。HSV－2、C型病毒可以通过调节P^53、C－myc基因的表达从而诱导小鼠白血病的发生。     

抑癌基因P53与肾母细胞瘤的研究进展

目的 :介绍近年来肾母细胞瘤(wilm瘤)与P53基因的研究进展。方法:查阅国内外有关文献进行综述。结果 :在wilms瘤中存在P53基因的丢失、突变和异常表达。结论 :P53基因与wilm瘤的发生及预后明确相关。     

应用酵母双杂交技术筛选与p53相互作用的蛋白质

应用酵母双杂交技术筛选与p53发生相互作用的蛋白质,有助于进一步阐明其在肿瘤发生、发展中发挥重要作用的调控机制。采用酵母双杂交技术,以p53C末端（62-393aa）作为诱饵筛选人乳腺cDNA文库,寻找能与之相互作用的蛋白质．并运用报告基因等实验提供的信息,经过重复验证排除假阳性以确定最后的阳性克隆。以p53C末端（62～393aa）作为诱饵最终筛选出了一个阳性克隆,经测序及生物信息学分析,这一个阳性克隆为：PIAS3（Protein inhibitor of activated stat3）。说明了PIAS3蛋白能与p53（62-393aa）发生特异性的相互作用。     

用计算机对人类TSPYl基因P53结合位点的鉴定

根据p53下游基因在其调节区域（启动子或内含子）含有与P53蛋白特异性结合的一致性序列5’-RRRCWWGYYYN（0-13）RRRCWWGYYY-3’，R—G或A，W—T或A，Y—C或T，N—A，C，T，G。用计算机对人类基因组中P53结合位点进行了研究，发现Y染色体上的TSPY1基因内含子中含有这样的一致性序列5’-GGGCTAGTTTtgGAGCTAGCCT-3’，意味着TSPY1基因有可能是一个p53下游基因。     

p53蛋白在胃癌和结肠癌中的表达

目的　研究 p5 3蛋白在胃癌和结肠癌中的表达 ,分析其与临床及病理因素的关系 .方法　采用免疫组织化学S P法 ,对外科手术切除的胃癌 2 0例、结肠癌 39例的癌体标本组织中 p5 3蛋白的表达进行检测 .结果　p5 3蛋白在胃癌和结肠癌标本组中阳性的表达在细胞核 ,其阳性表达率在胃癌和结肠癌标本中分别为 80 %和 4 8.7% .结论　p5 3蛋白的阳性表达与肿瘤的浸润深度无关 (P >0 .0 5 ) ,而与肿瘤的分化程度及淋巴结转移呈相关关系 (P <0 .0 5 ) .     

髓母细胞瘤中P53、bcl-2及Ki-67的表达及其意义

用免疫组化S P法检测 2 5例髓母细胞瘤中Ki 6 7、P53 及bcl 2基因的表达。结果表明 ,在 2 5例髓母细胞瘤中 ,bcl 2和P53 蛋白的阳性表达率分别为 72 % (18/ 2 5 )和 16 % (4/ 2 5 )。Ki 6 7阳性率平均为 (33.34± 4 .98) % ,其表达与组织学分型有关。说明在髓母细胞瘤中bcl 2蛋白与P53 蛋白可能参与调控细胞的凋亡     

Functional and physical communication between oncoproteins and tumor suppressors

The discovery of oncogenes (c-onc’s) and tumor suppressors (TS’s) has led to the concept that cancer arises from defects in each of these classes of genes or their products. More recently, it has been appreciated that c-onc and TS proteins often affect one another’s functions. Within this context, I review the two classical TS’s, p53 and the retinoblastoma protein, and the consequences of their inactivation. The various forms of genomic instability (GI) that underly the high mutation rates of transformed cells are then discussed. Particular emphasis is placed upon the concept that GI is not only an integral part of the transformed state but is a prerequisite. Increased oxidative DNA damage, and/or an inabiliy to repair it, can lead to GI. The review then discusses recent observations showing that loss of the TS protein peroxiredoxin 1 (prdx1) and increased expression of the c-onc protein c-Myc, each leads to increased oxidative DNA damage. The critical nature of the c-onc-TS interaction is underscored by that occurring between prdx1 and c-Myc, with the former protein regulating the production of DNA-damaging reactive oxygen species by the latter. The intimate association between these proteins and others serves as a paradigm for the exquisite balancing act that c-onc’s and TS’s must maintain in order to properly control normal DNA replication and cellular proliferation while simultaneously minimizing the acquisition of potentially neoplastic mutations. Received 10 May 2005; received after revision 3 July 2005; accepted 19 July 2005     

人参皂甙Rh2对PC-3在裸鼠体内生长的抑制作用研究

目的 本实验以人激素非依赖性前列腺癌细胞株PC-3为对象,探讨Rh2对PC-3在体内实验中有无抑制作用.方法 用免疫组织化学技术检测Bcl-2在各组之间表达差异.结果 在体内实验中,Rh2对前列腺癌PC-3具有明显的抑制作用.结论 Rh2对前列腺癌PC-3具有明显的抑制作用.     

免疫PCR方法检测乳腺癌患者血清抗p53蛋白抗体

目的为乳腺癌诊断提供血清学新方法.方法免疫PCR方法检测血清抗p53蛋白抗体,酶免疫组化方法检测组织p53蛋白表达.结果乳腺癌患者血清抗p53蛋白抗体阳性率为39.5%,而非癌患者和正常人血清抗p53蛋白抗体均为阴性,乳腺癌患者血清中抗p53蛋白抗体显著高于非癌患者和正常人(P＜0.01).p53蛋白阳性表达的乳腺癌患者抗p53蛋白抗体阳性率为64.2%,明显高于p53蛋白阴性表达组,血清p53抗体测定与p53蛋白表达密切相关(P＜0.01).结论检测血清抗p53蛋白抗体是检测组织p53蛋白理想的替代工具抗p53蛋白抗体可以作为乳腺癌血清学诊断新标志,用于乳腺癌的普查和早期诊断.     

Dynamic analysis of DNA damage induced miRNAs in colon cancer cells

It is known that microRNAs （miRNAs） expression profile shows substantial changes in cells under DNA damage. Here, we did miRNA microarray and quantitative real-time PCR to comprehensively identify the differentially expressed miRNAs in colon cancer cell lines HCT116 p53＋/＋ and HCT116 p53-/-. Cluster analysis revealed a panel of differentially expressed miRNAs which are regulated by p53 and/or UV-C induced DNA damage. These altered miRNAs tend to be located in chromosomes 13, X and 17. Moreover, pathways enrichment analysis estimated that MAPK pathway, focal adheren pathway, p53 pathway and Wnt pathway were mediated by these miRNAs to exert their functions in DNA damage response. Additionally, we found that miR- 320a, one of the UV-C induced miRNAs, play a role in protecting cells from DNA damage. Taken together, our results show that miRNAs are dynamic regulated in p53- dependent or -independent manners in different cell contexts and different situations following DNA damage.